輸入代號或公司名稱後按 Enter
4162

智擎

-0.80 (-1.46%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
54.00487成交張數14.59本益比1.58股價淨值比3.70%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.93615.4%3.751.3451.9%2.69%11.26%
2026Q10.9635.2%2.951.3757.2%2.75%8.00%
2025Q40.91-90.8%2.701.3146.0%2.70%7.51%
2025Q30.9548.4%11.661.3656.4%2.89%38.17%
2025Q20.13-88.3%11.350.189.0%0.35%38.15%
2025Q10.7124.6%12.331.0254.6%1.88%37.50%
2024Q49.873696.2%12.1914.1875.5%30.24%37.81%
2024Q30.6414.3%2.580.9242.2%2.34%9.48%
2024Q21.11113.5%2.501.5960.7%4.06%9.40%
2024Q10.570.0%1.910.8249.7%2.09%6.96%
2023Q40.26-29.7%1.910.3720.0%0.97%7.10%
2023Q30.56-8.2%2.020.8132.9%2.13%7.61%
2023Q20.52-7.1%2.070.7545.2%1.95%7.96%
2023Q10.57-16.2%2.110.8148.3%2.08%7.59%
2022Q40.37-52.6%2.220.5433.8%1.39%8.16%
2022Q30.6119.6%2.630.8756.5%2.32%9.85%
2022Q20.56-50.9%2.530.8148.3%2.08%9.18%
2022Q10.6830.8%3.110.9755.7%2.43%11.02%
2021Q40.78-78.3%2.951.1254.7%2.87%10.72%
2021Q30.51292.3%5.760.7341.3%1.83%22.89%
2021Q21.141166.7%5.381.66104.7%4.01%20.50%
2021Q10.5252.9%4.330.7665.5%1.87%16.57%
2020Q43.594.155.2366.5%13.94%16.13%
2020Q30.13-23.5%0.300.1819.2%0.53%1.27%
2020Q20.09-52.6%0.340.1416.0%0.41%1.43%
2020Q10.3479.0%0.440.4958.3%1.39%1.80%
2019Q4-0.26-213.0%0.29-0.37-49.3%-1.06%1.19%
2019Q30.17-66.7%0.780.2429.0%0.68%3.14%
2019Q20.19-59.6%1.120.2936.0%0.81%4.60%
2019Q10.191.400.2734.9%0.74%5.50%
2018Q40.23-93.9%0.880.3443.6%0.92%3.40%
2018Q30.51168.4%4.400.7453.4%2.01%18.28%
2018Q20.474.080.70166.1%1.87%16.26%
2018Q1-0.333.15-0.49-145.4%-1.26%12.27%
2017Q43.75-10.9%2.635.5270.3%15.19%10.04%
2017Q30.193.09-0.04-12.3%-0.11%13.84%
2017Q2-0.46-128.0%2.05-0.35-121.8%-1.01%11.19%
2017Q1-0.854.15-1.26-1146.3%-3.35%17.79%
2016Q44.214.716.1676.5%17.68%
2016Q3-0.85-0.91-3287.5%-2.89%